Trial
NCT00003405
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Rush University Medical Center
Collaborators
National Cancer Institute (NCI)
Condition
Leukemia
Intervention
recombinant interferon alfa
Why stopped
No enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-14